"Together with a support staff of nurses, medical assistants, technologists, and patient representatives, we offer our patients the highest level of cardiovascular care in an environment of trust and compassion."

During the past decade, Missouri Cardiovascular Specialists conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Missouri Cardiovascular Specialists" #1 sponsor was "Medtronic" with 4 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Missouri Cardiovascular Specialists" #1 collaborator was "Duke Clinical Research Institute" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator, "Bright Research Partners" with 1 trials as a collaborator and "Deborah Heart and Lung Center" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Missouri Cardiovascular Specialists" are "Heart Failure" (6 trials), "Coronary Artery Disease" (3 trials), "Acute Coronary Syndrome" (2 trials), "Cardiovascular Disease" (2 trials) and "Myocardial Infarction" (2 trials). Many other conditions were trialed in "Missouri Cardiovascular Specialists" in a lesser frequency.

Most popular intervention types in "Missouri Cardiovascular Specialists" are "Device" (13 trials), "Drug" (12 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apixaban" (3 trials), "Acetylsalicylic acid" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "99mTechnicium (sestamibi or tetrofosmin)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Missouri Cardiovascular Specialists" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Missouri Cardiovascular Specialists". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in Missouri Cardiovascular Specialists, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Missouri Cardiovascular Specialists, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".